R. Michael Carruthers


Michael Carruthers joined Edgewise Therapeutics in September 2020 as our Chief Financial Officer. Mr. Carruthers has over 20 years of experience serving as Chief Financial Officer for publicly-traded biopharmaceutical companies, with extensive experience across corporate finance and strategic planning including IPO’s, secondary offerings and M&A...

Roles at Edgewise Therapeutics

  • CFO

    Current role

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.